With respect to GB molecular subtype classification (5), some 85 patients of the original 152 cohort were sub-typed, and within which we found Cav-1 tumour expression to be significantly greater in the mesenchymal and proneural GB subtypes (combined 60% of the population). This evidence concerns the gene CAV1 and neoplasm.